http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2413525-C2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_b0a82b1df3712011553ee7f3d0126c30 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K35-48 |
| filingDate | 2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2011-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f363da2acafe4b4be39839afbdd1e52a http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_cc1fa1944cb3c56341f16a2165b056d5 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_01d2f041f9cbd38060312751e7425016 |
| publicationDate | 2011-03-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | RU-2413525-C2 |
| titleOfInvention | Method for preparing drug for prostate function recovery |
| abstract | FIELD: medicine. n SUBSTANCE: invention refers to technology of biologically active agents (BAA) of animal origin. A method for preparing a BAA for prostate function recovery involves grinding bull and/or puberty bull-calf prostate tissue, homogenising the intermediate product, keeping the homogenate in 3% aqueous solution of acetic acid and zinc chloride (ZnCl 2 ), separating water-soluble components of animal tissue cells by centrifugation to produce a supernatant to be concentrated, purified by ultrafiltration, adding glycine to the solution, sterilising and drying an end product. The solution of acetic acid is prepared of apyrogenic water; the homogenate is kept in the solution of acetic acid and zinc chloride at temperature 3-7°C for 48 h in being agitated by 0.5 portions every 4 h. The ultrafiltration process is executed in a circulation mode through a flat-chamber membrane installation with membrane filters of characteristic pore size d=300 A at temperature T≤10°C to produce a solution to be concentrated with the use of nano-filter compositional membranes. It enables to prepare an end product concentrate containing mixed ingredients of molecular weight M=5÷20.0 kDa to be dried by means of a spray-type drier. n EFFECT: method allows producing a high-yield powered therapeutically effective agent containing water-soluble ingredients of M<20,0 kDa. n 4 cl, 1 ex, 2 dwg |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/RU-2579313-C1 |
| priorityDate | 2004-04-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 24.